[HTML][HTML] B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4

DA Mandelbrot, MA Oosterwegel… - The Journal of …, 2001 - Am Soc Clin Investig
DA Mandelbrot, MA Oosterwegel, K Shimizu, A Yamada, GJ Freeman, RN Mitchell…
The Journal of clinical investigation, 2001Am Soc Clin Investig
To examine whether B7 costimulation can be mediated by a molecule on T cells that is
neither CD28 nor CTLA4, we generated mice lacking both of these receptors. CD28/CTLA4–
/–mice resemble CD28–/–mice in having decreased expression of T-cell activation markers
in vivo and decreased T-cell proliferation in vitro, as compared with wild-type mice. Using
multiple approaches, we find B7-dependent costimulation in CD28/CTLA4–/–mice. The
proliferation of CD28/CTLA4–/–T cells is inhibited by CTLA4-Ig and by the use of antigen …
To examine whether B7 costimulation can be mediated by a molecule on T cells that is neither CD28 nor CTLA4, we generated mice lacking both of these receptors. CD28/CTLA4–/– mice resemble CD28–/– mice in having decreased expression of T-cell activation markers in vivo and decreased T-cell proliferation in vitro, as compared with wild-type mice. Using multiple approaches, we find B7-dependent costimulation in CD28/CTLA4–/– mice. The proliferation of CD28/CTLA4–/– T cells is inhibited by CTLA4-Ig and by the use of antigen-presenting cells lacking both B7-1 and B7-2. CD28/CTLA4–/– T-cell proliferation is increased by exposure to Chinese hamster ovary cells transfected with B7-1 or B7-2. Finally, administration of CTLA4-Ig to CD28/CTLA4–/– cardiac allograft recipients significantly prolongs graft survival. These data support the existence of an additional receptor for B7 molecules that is neither CD28 nor CTLA4.
The Journal of Clinical Investigation